Rutledge Foundation Grants $55,000 To Continue Work On Less Toxic Nanoparticle Drug Delivery For Pediatric Sarcomas

In March, Rutledge Foundation granted $55,000 to help continue Dr. Andras Lacko’s work on a Lipoprotein Delivery System for pediatric cancers at UNT Health Science Center. This new nanoparticle delivery system hopes to minimize the short and long term side effects of otherwise toxic chemotherapies and other targeted therapies.  A collaboration between UNTHSC and Texas Children’s Hospital, initiated by the Rutledge Foundation, is underway to move this exciting new drug delivery into animal studies, followed by clinical trials.